By exploring various mechanisms of chronic inflammation-associated diseases, such atherosclerosis, obesity, and insulin resistance, IKKβ and its regulated main canonical NF-κB pathway in various cell types have been found to play diverse roles in cardiometabolic disease development. Here, NFKB1 is linked to obesity disorder.